EverSource Wealth Advisors »

Outlook Therapeutics shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $737 696 1.06
2025-06-30 $1.3k 822 1.60
2025-03-31 $583 494 1.18
2024-12-31 $355 188 1.89

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Value Etf Etf (VTV)
iShares Gold Trust ETF Etf (IAU)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Fidelity Wise Origin Bitcoin Fund Etf (FBTC)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Praxis Impact Large Cap Value Etf Etf (PRXV)
Microsoft Corp Stock (MSFT)
Tesla Stock (TSLA)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Total Stock Market Etf Etf (VTI)
Broadcom Stock (AVGO)
Palantir Technologies Inc Cl A Stock (PLTR)

View all positions for EverSource Wealth Advisors

Top funds holding Outlook Therapeutics

Vanguard Group
Schonfeld Strategic Advisors
Morgan Stanley
BlackRock
Geode Capital Management
Susquehanna International
Millennium Management
Commonwealth Equity Services
Simplex Trading
State Street Corporation
Scotia Capital
LVW Advisors
UBS Group
Citadel Advisors
Goldman Sachs Group

View all funds holding Outlook Therapeutics